Company: TVRD
Filing Date: 2025-10-20
Form Type: S-1/A
Source: 0001104659-25-100896
Chunk: 141

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-20
Form: S-1/A
Chunk 141
---
 | ​ | ​ | ​ | ​       | ​ | (51.6)% | ​ | ​ |

85

TABLE OF CONTENTS

Research and Development Expenses Research and development expenses for the three and six months ended June 30, 2025 and 2024 were comprised of the following (in thousands, except percentages):

| ​                                                    
 ​                                                    
 Direct research and development expenses by program: 
 TTI-101:                                             | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | Three MonthsEndedJune 30, 
 2025                      
 ​                         
 ​                         | ​ 
 ​ |     ​ 
     ​ | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | 2024 
 ​    
 ​    | ​ 
 ​ |     ​ 
     ​ | ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | Change 
 Amount 
 ​      
 ​      | ​ 
 ​ |      ​ 
      ​ | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Percent 
 ​       
 ​       | ​ 
 ​ | ​        
 ​        | ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | Six MonthsEndedJune 30, 
 2025                    
 ​                       
 ​                       | ​ 
 ​ |     ​ 
     ​ | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | 2024 
 ​    
 ​    | ​ 
 ​ |      ​ 
      ​ | ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ | Change 
 Amount 
 ​      
 ​      | ​ 
 ​ |      ​ 
      ​ | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Percent 
 ​       
 ​       | ​ 
 ​ | ​        
 ​        | ​ 
 ​ | ​ 
 ​ 
 ​ 
 ​ |
|:-----------------------------------------------------|:--|:--|:--------------------------|:--|------:|:--|:--|:--|:-----|:--|------:|:--|:--|:--|:-------|:--|-------:|:--|:--|:--|:--------|:--|:---------|:--|:--|:--|:------------------------|:--|------:|:--|:--|:--|:-----|:--